Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Second Case of Rat Hepatitis E Virus Identified in Hong Kong
Through retrospective analysis, investigators have identified a second case of rat hepatitis E virus in a human, which has close genetic relation to the first case.
SVR Possible in PWID Infected With Hepatitis C Virus Despite Imperfect Adherence to Treatment
People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.
Hepatitis C Treatment Time Could Be Cut in Half in Some Patients: A Proof of Concept Study
A new approach to hepatitis C virus infection treatment could shave time and costs off the current standard regimen.
HIV and NAFLD More Common Than Originally Thought
Research on nonalcoholic fatty liver disease in persons infected with HIV revealed a prevalence of the condition of about 40%, suggesting the condition may be an underappreciated comorbidity in this population.
Hepatitis C Virus Retreatment Successful with SOF/VEL/VOX in Patients With and Without HIV
A fixed-dose combination therapy (Vosevi, Gilead) was highly effective after 12 weeks in retreating direct-acting antiviral-experienced patients with hepatitis C virus infection, with and without HIV co-infection, including those with prior noncompletion of treatment or poor adherence.
Direct-Acting Antiviral Therapy Effective for Curing Hepatitis C in Injection Drug Users
A recent study by the Kirby Institute reported that after using direct-acting antiviral therapy 97% of participants with HCV who recently used injectable drugs achieved sustained viral response.
Hepatitis A Outbreak in West Virginia Leaves Officials Scrambling
West Virginia’s Bureau for Public Health has requested the assistance from the CDC to contain the statewide hepatitis A outbreak.
Two Genes Identified as Potential Drug Targets in Treatment of HIV
New research from Johns Hopkins reveals that 2 genes, CMPK2 and BCLG, are selectively activated in the presence of type 1 interferon.
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.